News for 'National Centre for Biotechnology Information'

India, US in talks for mutually beneficial trade agreement

India, US in talks for mutually beneficial trade agreement

Rediff.com30 Jan 2026

The Indian government informed Parliament that India and the US are engaged in negotiations for a mutually beneficial multi-sectoral bilateral trade agreement. The two countries also cooperate on strategic, economic, and defense matters, managing divergences through high-level dialogues.

How to study PhD at the Regional Centre for Biotechnology

How to study PhD at the Regional Centre for Biotechnology

Rediff.com15 Apr 2024

The selected students (20 seats are available) will undergo coursework followed by research leading to a doctoral thesis under the mentorship of a faculty.

'Companies Will Be More Powerful Than Nations'

'Companies Will Be More Powerful Than Nations'

Rediff.com19 Aug 2025

'If you align your ambition with India's rise, the peak of your careers will unfold alongside the peak of India's power.'

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025: Grassroot Level Implementation Is Necessary

Rediff.com5 Feb 2025

Simplifying investment policies at the micro level and introducing a time-bound framework will be critical for India's growth targets, notes Krishna Ella.

US pledges to boost technology ties with India

US pledges to boost technology ties with India

Rediff.com14 Feb 2025

Artificial Intelligence, innovation and next-generation technologies figured prominently during the high-stakes discussion between Prime Minister Narendra Modi and US President Donald Trump at the White House, as the two sides announced transformative measures, including the US-India TRUST initiative, roadmap on accelerating AI infrastructure and INDUS Innovation, to boost tech ties.

India sees biggest Chandipura virus outbreak in 20 yrs: WHO

India sees biggest Chandipura virus outbreak in 20 yrs: WHO

Rediff.com29 Aug 2024

A total of 43 districts in India are currently reporting AES cases.

ISRO, NASA in talks to place Indian on ISS next year

ISRO, NASA in talks to place Indian on ISS next year

Rediff.com8 Sep 2023

India and the US on Friday said they have started talks to put in place a strategic framework for human space flight by year-end as they plan to send an Indian astronaut to the International Space Station in 2024.

More testing, check hotspots: Centre to states on 'Omicron'

More testing, check hotspots: Centre to states on 'Omicron'

Rediff.com28 Nov 2021

As a proactive step, the government has already placed nations, where this VoC has been found, in the category of 'at risk' countries for additional follow-up measures of international travellers coming into lndia from these destinations, he said in a letter dated November 27.

Can wrong footwear cause health problems?

Can wrong footwear cause health problems?

Rediff.com23 Jul 2021

Approximately 72% people wear inappropriate sized footwear which is associated with all kind of foot problems.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Govt exploring possibility to produce Covaxin abroad

Govt exploring possibility to produce Covaxin abroad

Rediff.com21 May 2021

To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.

COVID effect: No motorcycle stunts at R-Day parade this year

COVID effect: No motorcycle stunts at R-Day parade this year

Rediff.com23 Jan 2021

The spectator size too has been reduced to 25,000, officials said.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

India, Malaysia ICT meet in Jan '05

India, Malaysia ICT meet in Jan '05

Rediff.com26 Nov 2004

A two-day conference to highlight emerging business opportunities in India and Malaysia, especially in Information Communication Technology, business process outsourcing and biotechnology sectors, will be held in January 2005 in the Malaysia.

Four states report 14 new Omicron cases, India tally rises to 87

Four states report 14 new Omicron cases, India tally rises to 87

Rediff.com16 Dec 2021

While Karnataka reported five new cases, Delhi and Telangana reported four each, and Gujarat reported one fresh case of the Omicron variant.

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Rediff.com25 May 2021

Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.

Lockdown tamed doubling rate of COVID-19 cases: Health ministry

Lockdown tamed doubling rate of COVID-19 cases: Health ministry

Rediff.com17 Apr 2020

Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

47% Covid victims in India aged below 60 years: Govt

47% Covid victims in India aged below 60 years: Govt

Rediff.com13 Oct 2020

"Also, 35 per cent deaths were recorded in the age group of 45-60 years, 10 per cent in the age group of 26-44 years and one per cent each in the age group of 18-25 years and below 17 years," the health secy said.

'Mumbai needs a CEO to become a global financial hub'

'Mumbai needs a CEO to become a global financial hub'

Rediff.com5 Dec 2014

There is a need to have a 'CEO for Mumbai' in order to realise the ambition of making it a global financial centre.

What are locusts? And why are they such a big menace?

What are locusts? And why are they such a big menace?

Rediff.com5 Aug 2020

Swarms of immature pink locusts and adult yellow locusts are currrently active. Not only are fresh locusts swarms expected to arrive in the coming weeks, but even those already present in India have mated and are breeding new offspring.

Chopper scam: Budget session likely casualty as Centre, Congress trade charges

Chopper scam: Budget session likely casualty as Centre, Congress trade charges

Rediff.com28 Apr 2016

With an aggressive Opposition and unyielding government, important legislation could be the biggest casualty, as details of the helicopter contract surface.

How to apply for Rhodes Scholarship 2017

How to apply for Rhodes Scholarship 2017

Rediff.com8 Jul 2016

Selected candidates will get to pursue a fully funded course of their choice at the University of Oxford.

India's COVID-19 Crisis May Get Worse

India's COVID-19 Crisis May Get Worse

Rediff.com15 Jun 2020

'As people have moved from cities to small towns and villages, they have carried the infection into new territories.' 'Poor healthcare infrastructure in these places should be a big worry in the days to come.'

Why Rashtrapati's Israel visit goes beyond politics

Why Rashtrapati's Israel visit goes beyond politics

Rediff.com13 Oct 2015

President Pranab Mukherjee's visit to Israel is a final and critical step in the normalisation of relations between the two countries.

Thanks to Modi's push, GM mustard set to hit Indian markets

Thanks to Modi's push, GM mustard set to hit Indian markets

Rediff.com22 Jun 2015

Modi government is pushing GM food crops without adequate safety assessment and transparency, claim activists.

Congress banks on Siddaramaiah's 'Karnataka model of development' to see it through

Congress banks on Siddaramaiah's 'Karnataka model of development' to see it through

Rediff.com11 Apr 2018

The IIM-B's 'Karnataka innovation report' has become the basis for the Congress party's election narrative, particularly to distinguish it from the 'Gujarat model of development', reports Archis Mohan.

2018's top 20 science colleges in India

2018's top 20 science colleges in India

Rediff.com30 May 2018

Presenting the Top 20 of 100 science colleges as per India Today's findings.

2018's top 20 science colleges in India

2018's top 20 science colleges in India

Rediff.com30 May 2018

Presenting the Top 20 of 100 science colleges as per India Today's findings.

How India's young innovators do well by doing good

How India's young innovators do well by doing good

Rediff.com25 May 2018

'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.

Full text: What Modi, Obama agreed on

Full text: What Modi, Obama agreed on

Rediff.com25 Jan 2015

This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.

Manik Sarkar: The anomaly in Indian politics

Manik Sarkar: The anomaly in Indian politics

Rediff.com23 Oct 2013

Tripura's popular chief minister shows up the failures of the elitist central leadership of India's Left, says Devesh Kapur

We can restore the growth momentum, PM tells Indonesian newspaper

We can restore the growth momentum, PM tells Indonesian newspaper

Rediff.com10 Oct 2013

Trade between India and Indonesia stands at $20 billion.

Bon appetit Mr Modi!

Bon appetit Mr Modi!

Rediff.com9 Apr 2015

'Make in India' will be central to Mr Modi's visit to Europe and Canada. It is difficult to predict what will happen with the Rafale deal, but if it goes through, it will undoubtedly become the 'Mother' of all 'Make in India' projects,' says Claude Arpi.

'We know India can run -- judging by cricket -- but can it fly?'

'We know India can run -- judging by cricket -- but can it fly?'

Rediff.com18 Mar 2015

The elements are all aligned to make India a global powerhouse, says IMF Managing Director Christine Lagarde.

Ruskin Bond: If I can't write, I might as well be dead

Ruskin Bond: If I can't write, I might as well be dead

Rediff.com22 Dec 2014

'I like the thought that I am competing successfully with writers much younger than me,' says Ruskin Bond.